Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Stifel Healthcare Conference inNew York, NY onWednesday, November 14, 2018 at9:30 a.m. EST /2:30 p.m. GMT .Bruce Cozadd , chairman and chief executive officer, will provide an overview of the company and a business and financial update.Jefferies London Healthcare Conference inLondon onWednesday, November 14, 2018 at9:20 a.m. GMT /4:20 a.m. EST .Iain McGill , senior vice president, Jazz Pharmaceuticals Europe and rest of world, will provide an overview of the company and a business and financial update.Evercore ISI Healthcare Conference inBoston, MA onTuesday, November 27, 2018 at8:00 a.m. EST /1:00 p.m. GMT .Matt Young , executive vice president and chief financial officer, will provide an overview of the company and a business and financial update.Piper Jaffray 30th Annual Healthcare Conference inNew York, NY onWednesday, November 28, 2018 at11:00 a.m. EST /4:00 p.m. GMT .Matt Young , executive vice president and chief financial officer, will provide an overview of the company and a business and financial update.
A live audio webcast of each presentation may be accessed from the Investors section of the
An archive of the webcast will be available for at least one week following the presentation on the Investors section of the company's website at http://www.jazzpharmaceuticals.com.
About
View original content to download multimedia:http://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-300745911.html
SOURCE
Investors: Kathee Littrell, Vice President, Investor Relations, Ireland, +353 1 634 7887, U.S., +1 650 496 2717; Media: Jacqueline Kirby, Vice President, Corporate Affairs & Government Relations, Ireland, +353 1 697 2141, U.S., +1 215 867 4910